Find Sodium Oxybate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 502-85-2, Sodium 4-hydroxybutyrate, Anetamin, 4-hydroxybutyric acid sodium salt, Sodium 4-hydroxybutanoate, Somsanit
Molecular Formula
C4H7NaO3
Molecular Weight
126.09  g/mol
InChI Key
XYGBKMMCQDZQOZ-UHFFFAOYSA-M
FDA UNII
7G33012534

Sodium Oxybate
The sodium salt of 4-hydroxybutyric acid. It is used for both induction and maintenance of ANESTHESIA.
1 2D Structure

Sodium Oxybate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
sodium;4-hydroxybutanoate
2.1.2 InChI
InChI=1S/C4H8O3.Na/c5-3-1-2-4(6)7;/h5H,1-3H2,(H,6,7);/q;+1/p-1
2.1.3 InChI Key
XYGBKMMCQDZQOZ-UHFFFAOYSA-M
2.1.4 Canonical SMILES
C(CC(=O)[O-])CO.[Na+]
2.2 Other Identifiers
2.2.1 UNII
7G33012534
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4 Hydroxybutyrate Sodium

2. 4-hydroxybutyrate Sodium

3. Gamma Hydroxybutyrate

4. Gamma-hydroxybutyrate

5. Oxybate Sodium

6. Oxybate, Sodium

7. Oxybutyrate, Sodium

8. Sodium Gamma Hydroxybutyrate

9. Sodium Gamma-hydroxybutyrate

10. Sodium Oxybutyrate

11. Somsanit

12. Xyrem

2.3.2 Depositor-Supplied Synonyms

1. 502-85-2

2. Sodium 4-hydroxybutyrate

3. Anetamin

4. 4-hydroxybutyric Acid Sodium Salt

5. Sodium 4-hydroxybutanoate

6. Somsanit

7. Oxybate Sodium

8. Gamma Oh

9. Sodium Oxybate [usan]

10. Sodium Oxybutyrate

11. Catabate

12. Sodium Oxybat

13. Oxybate (sodium)

14. 4-hydroxybutyrate Sodium

15. Wy-3478

16. Butanoic Acid, 4-hydroxy-, Monosodium Salt

17. Gamma-hydroxybutyrate Sodium

18. Sodium Gamma-hydroxybutyrate

19. Sodium;4-hydroxybutanoate

20. Gamma-hydroxy Sodium Butyrate

21. Butanoic Acid, 4-hydroxy-, Sodium Salt

22. Eb 27

23. Hydroxybutyric Acid Monosodium Salt

24. 4-hydroxybutyric Acid Monosodium Salt

25. Wy 3478

26. .gamma.-hydroxybutyrate Sodium Salt

27. Nsc-84223

28. Sodium Oxybate (usan)

29. 7g33012534

30. Butyric Acid, 4-hydroxy-, Monosodium Salt

31. Butyric Acid, 4-hydroxy-, Sodium Salt

32. Natrium 4-hydroxybutyrat

33. Sodium-4-hydroxybutyrate

34. Sodium Oxybate (sodium 4-hydroxybutanoate)

35. Ghb Sodium Salt (sodium Gammahydroxybutyrate)

36. 4-hydroxybuttersaeure Natriumsalz

37. Gamma-hydroxybutyrate Sodium Salt

38. Ncgc00247714-01

39. Einecs 207-953-3

40. Nsc 84223

41. Gamma-hydroxybutyric Acid, Sodium Salt

42. Jzp-6

43. Sodium4-hydroxybutyrate

44. Acetamide,2,2-dichloro-n-[(1r,2r)-2-hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]-,rel-

45. Unii-7g33012534

46. Xyrem (tn)

47. Sodium Gammahydroxybutyrate

48. Dsstox_cid_28866

49. Dsstox_rid_83135

50. Dsstox_gsid_48940

51. Schembl61823

52. Sodium Oxybate [hsdb]

53. Sodium Oxybate [vandf]

54. Dea No. 2012

55. Sodium Oxybate [mart.]

56. Chembl1200682

57. Dtxsid3048940

58. Oxybate Sodium [who-dd]

59. Sodium Oxybate [ema Epar]

60. Hms2091e15

61. Hy-b1187

62. Tox21_112871

63. Sodium Oxybate [orange Book]

64. Gamma Hydroxybutyric Acid Preparations

65. Xywav Component Sodium Oxybate

66. Akos006221428

67. Ccg-212465

68. Cs-4796

69. Db09072

70. Sodium Oxybate Component Of Xywav

71. Cas-502-85-2

72. Db-071156

73. Ft-0626615

74. D05866

75. H-4040

76. Sodium Salt Of Gamma-hydroxybutyric Acid

77. .gamma.-hydroxybutyrate Sodium Salt [mi]

78. Butanoic Acid, 4-hydroxy-, Sodium Salt (1:1)

79. Q7553347

80. 90318-49-3

2.4 Create Date
2008-02-05
3 Chemical and Physical Properties
Molecular Weight 126.09 g/mol
Molecular Formula C4H7NaO3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass126.02928836 g/mol
Monoisotopic Mass126.02928836 g/mol
Topological Polar Surface Area60.4 Ų
Heavy Atom Count8
Formal Charge0
Complexity64.3
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameXyrem
PubMed HealthSodium Oxybate (By mouth)
Drug ClassesCentral Nervous System Agent
Drug LabelSodium oxybate, a CNS depressant, is the active ingredient in Xyrem. The chemical name for sodium oxybate is sodium 4-hydroxybutyrate. The molecular formula is C4H7NaO3, and the molecular weight is 126.09 g/mole. The chemical structure is:Sodium oxyb...
Active IngredientSodium oxybate
Dosage FormSolution
RouteOral
Strength500mg/ml
Market StatusPrescription
CompanyJazz Pharms

2 of 2  
Drug NameXyrem
PubMed HealthSodium Oxybate (By mouth)
Drug ClassesCentral Nervous System Agent
Drug LabelSodium oxybate, a CNS depressant, is the active ingredient in Xyrem. The chemical name for sodium oxybate is sodium 4-hydroxybutyrate. The molecular formula is C4H7NaO3, and the molecular weight is 126.09 g/mole. The chemical structure is:Sodium oxyb...
Active IngredientSodium oxybate
Dosage FormSolution
RouteOral
Strength500mg/ml
Market StatusPrescription
CompanyJazz Pharms

4.2 Drug Indication

For the treatment of cataplexy and excessive daytime sleepiness (EDS) associated with narcolepsy.


FDA Label


Treatment of narcolepsy with cataplexy in adult patients.


Substitution treatment for alcohol dependence within a framework of careful medical supervision along with continuous psychosocial support and social rehabilitation. Treatment should be initiated only in patients resistant to existing interventions or in patients for whom existing therapies are contra-indicated or not recommended. ,


5 Pharmacology and Biochemistry
5.1 Pharmacology

Sodium oxybate works through an unknown mechanism to treat narcolepsy by inducing sleep within about 5-15 minutes of administration.


5.2 MeSH Pharmacological Classification

Adjuvants, Anesthesia

Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)


Anesthetics, Intravenous

Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)


5.3 FDA Pharmacological Classification
5.3.1 Pharmacological Classes
Central Nervous System Depression [PE]; Decreased Central Nervous System Organized Electrical Activity [PE]; Central Nervous System Depressant [EPC]
5.4 ATC Code

N07XX04


N07BB


B05XA02

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


N - Nervous system

N01 - Anesthetics

N01A - Anesthetics, general

N01AX - Other general anesthetics

N01AX11 - Sodium oxybate


N - Nervous system

N07 - Other nervous system drugs

N07X - Other nervous system drugs

N07XX - Other nervous system drugs

N07XX04 - Sodium oxybate


5.5 Absorption, Distribution and Excretion

Absorption

Absolute bioavailability is approximately 88%. Tmax of 30.7-51.9min.


Route of Elimination

The major metabolite is carbon dioxide which is cleared by expiration, less then 5% appears as the unchanged drug in the urine within 6-8 hours after dosing.


Volume of Distribution

Vd of 37.7-67.7


Clearance

Total clearance of 895-1361mL/min.


5.6 Metabolism/Metabolites

Animal studies indicate that the major elimination pathway is metabolism by the creation of carbon dioxide and water through the Krebs cycle and secondarily by beta-oxidation. In the primary pathway hydroxyacid-oxoacid transhydrogenase catalyzes the conversion of sodium oxybate to succinic semialdehyde which is then transformed to succinic acid by succinic semmialdehyde dehydrogenase. Succinic acid is then turned into carbon dioxide and water in the Krebs cycle. Succinic semialdehyde is also metabolised into carbon dioxide and water by a transhydrofenase in the presence of alpha ketoglutarate.


5.7 Biological Half-Life

0.5 to 1 hour.


5.8 Mechanism of Action

The exact mechanism of action is unknown. It is the sodium salt of the endogenous compound gamma hydroxybutyrate which is a metabolite of the GABA neurotransmitter and it's thought that it's therapeutic effects are mediated via GABA B actions at noradrenergic, dopaminergic and thalamocortical neurons.


USDMF

read-more
read-more

01

Veranova Lp

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2022-04-25

Pay. Date : 2022-02-28

DMF Number : 36577

Submission : 2022-02-18

Status : Active

Type : II

Veranova

02

Veranova Lp

U.S.A
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothVeranova: A CDMO that manages complexity with confidence.

Flag U.S.A
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-08-28

Pay. Date : 2012-12-19

DMF Number : 24049

Submission : 2010-08-02

Status : Active

Type : II

Veranova

03

SupplySide West 2024
Not Confirmed

03

SupplySide West 2024
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-10-06

Pay. Date : 2022-08-17

DMF Number : 28289

Submission : 2014-06-19

Status : Active

Type : II

blank

04

Apotex Pharmachem Inc

Canada

USDMF

arrow
SupplySide West 2024
Not Confirmed

05

SupplySide West 2024
Not Confirmed

05

SupplySide West 2024
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2022-05-31

Pay. Date : 2022-05-17

DMF Number : 35870

Submission : 2022-04-25

Status : Active

Type : II

blank

06

Curia Missouri Inc

U.S.A

USDMF

arrow
SupplySide West 2024
Not Confirmed

06

SupplySide West 2024
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2014-05-28

Pay. Date : 2013-12-06

DMF Number : 27599

Submission : 2013-09-26

Status : Active

Type : II

blank

07

Sigma F And D Div Ltd

U.S.A

USDMF

arrow
SupplySide West 2024
Not Confirmed

08

Tris Pharma Inc

U.S.A

USDMF

arrow
SupplySide West 2024
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-more

01

Rusan Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothRusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

Flag India
Digital Content Digital Content

Sodium Oxybate

Date of Issue : 2021-08-27

Valid Till : 2024-06-10

Written Confirmation Number : WC-0278

Address of the Firm : Plot No. 6406, GIDC Estate, Ankleshwar-393002, Dist. Bharuch, Gujarat

Rusan Pharma

02

SupplySide West 2024
Not Confirmed
arrow
arrow
SupplySide West 2024
Not Confirmed

Sodium Oxybate IH

Date of Issue : 2022-09-30

Valid Till : 2025-06-05

Written Confirmation Number : WC-0370

Address of the Firm : Plot No. 289-290 G.I.D.C Ankleshwar, Bharuch, Gujarat.

blank

03

SupplySide West 2024
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"SODIUM OXYBATE","year":"2021","qtr":"Q1","strtotime":1611858600,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S ODIUM) (GHB)","address":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MADRID","customer":"M\/S.","customerCountry":"SPAIN","quantity":"110.00","actualQuantity":"110","unit":"KGS","unitRateFc":"320.3","totalValueFC":"35673.3","currency":"USD","unitRateINR":23718.5,"date":"29-Jan-2021","totalValueINR":"2609035","totalValueInUsd":"35673.3","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"8245405","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"SODIUM OXYBATE","year":"2021","qtr":"Q2","strtotime":1620153000,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S ODIUM) (GHB)","address":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"M\/S.","customerCountry":"SPAIN","quantity":"225.00","actualQuantity":"225","unit":"KGS","unitRateFc":"285.4","totalValueFC":"63172.1","currency":"USD","unitRateINR":20565.835555555557,"date":"05-May-2021","totalValueINR":"4627313","totalValueInUsd":"63172.1","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"1572231","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627324200,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S","address":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"M\/S.","customerCountry":"SPAIN","quantity":"320.00","actualQuantity":"320","unit":"KGS","unitRateFc":"210","totalValueFC":"78052.5","currency":"EUR","unitRateINR":18178.125,"date":"27-Jul-2021","totalValueINR":"5817000","totalValueInUsd":"78052.5","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"3424862","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,VAKOLA, SANTACRUZ (E),, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1643221800,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"M\/S.","customerCountry":"SPAIN","quantity":"380.00","actualQuantity":"380","unit":"KGS","unitRateFc":"212","totalValueFC":"89672.3","currency":"EUR","unitRateINR":17578.947368421053,"date":"27-Jan-2022","totalValueINR":"6680000","totalValueInUsd":"89672.3","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"7750273","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645986600,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"M\/S.","customerCountry":"SPAIN","quantity":"400.00","actualQuantity":"400","unit":"KGS","unitRateFc":"211","totalValueFC":"94334.2","currency":"EUR","unitRateINR":17677.5,"date":"28-Feb-2022","totalValueINR":"7071000","totalValueInUsd":"94334.2","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"8587260","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646245800,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"M\/S.","customerCountry":"SPAIN","quantity":"400.00","actualQuantity":"400","unit":"KGS","unitRateFc":"211","totalValueFC":"89307.8","currency":"EUR","unitRateINR":17017.5,"date":"03-Mar-2022","totalValueINR":"6807000","totalValueInUsd":"89307.8","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"8659646","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646332200,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MADRID","customer":"M\/S.","customerCountry":"SPAIN","quantity":"75.00","actualQuantity":"75","unit":"KGS","unitRateFc":"280","totalValueFC":"22750.1","currency":"EUR","unitRateINR":23120,"date":"04-Mar-2022","totalValueINR":"1734000","totalValueInUsd":"22750.1","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"8696062","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1653330600,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"M\/S.","customerCountry":"SPAIN","quantity":"410.00","actualQuantity":"410","unit":"KGS","unitRateFc":"211","totalValueFC":"89693.1","currency":"EUR","unitRateINR":16907.317073170732,"date":"24-May-2022","totalValueINR":"6932000","totalValueInUsd":"89693.1","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"1600085","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1666981800,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"M\/S.","customerCountry":"SPAIN","quantity":"420.00","actualQuantity":"420","unit":"KGS","unitRateFc":"210","totalValueFC":"85301.9","currency":"EUR","unitRateINR":16711.904761904763,"date":"29-Oct-2022","totalValueINR":"7019000","totalValueInUsd":"85301.9","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"5121875","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670437800,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"M\/S","customerCountry":"SPAIN","quantity":"420.00","actualQuantity":"420","unit":"KGS","unitRateFc":"210","totalValueFC":"88913.1","currency":"EUR","unitRateINR":17445.238095238095,"date":"08-Dec-2022","totalValueINR":"7327000","totalValueInUsd":"88913.1","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"6004301","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678905000,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE S","address":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST","city":"MUMBAI,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"TO THE ORDER OF","customerCountry":"SPAIN","quantity":"335.00","actualQuantity":"335","unit":"KGS","unitRateFc":"210","totalValueFC":"73872","currency":"EUR","unitRateINR":18137.313432835821,"date":"16-Mar-2023","totalValueINR":"6076000","totalValueInUsd":"73872","indian_port":"BOMBAY AIR","hs_no":"29159099","bill_no":"8502956","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,,VAKOL A, SANTACRUZ - EAST, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1697740200,"product":"PHARMACEUTICAL PRODUCTS SODIUM OXYBATE","address":"ALKEM HOUSE, DEVASHISH ADJACENT TO","city":"LOWER PAREL, MUMBAI. MAHARASHTRA","supplier":"ALKEM LABORATORIES","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"LABOMED S,A, PHARMACEUTICAL INDUSTR","customerCountry":"GREECE","quantity":"32.00","actualQuantity":"32","unit":"KGS","unitRateFc":"200","totalValueFC":"5599","currency":"USD","unitRateINR":14562.5,"date":"20-Oct-2023","totalValueINR":"466000","totalValueInUsd":"5599","indian_port":"Bombay Air","hs_no":"29159099","bill_no":"4801185","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ALKEM HOUSE, DEVASHISH ADJACENT TO, LOWER PAREL, MUMBAI. MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1702405800,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE SODIUM) (GHB) [ACTIVE PHARMACEUTICAL INGREDIENTS]","address":"CENTAUR HOUSE, SHANTI NAGAR,","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"ATHENS","customer":"TO THE ORDER OF","customerCountry":"GREECE","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"950","totalValueFC":"2811","currency":"USD","unitRateINR":78000,"date":"13-Dec-2023","totalValueINR":"234000","totalValueInUsd":"2811","indian_port":"Bombay Air","hs_no":"29159099","bill_no":"6014681","productDescription":"API","marketType":"REGULATED MARKET","country":"GREECE","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708367400,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE SODIUM) (GHB)","address":"CENTAUR HOUSE, SHANTI NAGAR,","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"TO THE ORDER OF","customerCountry":"SPAIN","quantity":"232.00","actualQuantity":"232","unit":"KGS","unitRateFc":"240","totalValueFC":"57741.6","currency":"EUR","unitRateINR":20651.012931034482,"date":"20-Feb-2024","totalValueINR":"4791035","totalValueInUsd":"57741.6","indian_port":"Bombay Air","hs_no":"29159099","bill_no":"7667049","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1717093800,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE SODIUM) (GHB) [ACTIVE PHARMACEUTICAL INGREDIENTS]","address":"CENTAUR HOUSE, SHANTI NAGAR,","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"MADRID","customer":"TO THE ORDER OF","customerCountry":"SPAIN","quantity":"225.00","actualQuantity":"225","unit":"KGS","unitRateFc":"255","totalValueFC":"61475.3","currency":"EUR","unitRateINR":22774.322222222221,"date":"31-May-2024","totalValueINR":"5124222.5","totalValueInUsd":"61475.3","indian_port":"Bombay Air","hs_no":"29159099","bill_no":"1340953","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721241000,"product":"SODIUM OXYBATE [GAMMA HYDROXYBUTYRIC ACID SODIUM SALT (GHB)]","address":"ALKEM HOUSE, DEVASHISH ADJACENT TO","city":"LOWER PAREL, MUMBAI. MAHARASHTRA","supplier":"ALKEM LABORATORIES","supplierCountry":"INDIA","foreign_port":"BASEL","customer":"IMCD GROUP","customerCountry":"SWITZERLAND","quantity":"450.00","actualQuantity":"450","unit":"KGS","unitRateFc":"193.4","totalValueFC":"86300.9","currency":"USD","unitRateINR":16031.080733333334,"date":"18-Jul-2024","totalValueINR":"7213986.33","totalValueInUsd":"86300.9","indian_port":"Bombay Air","hs_no":"29159099","bill_no":"2522855","productDescription":"API","marketType":"REGULATED MARKET","country":"SWITZERLAND","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ALKEM HOUSE, DEVASHISH ADJACENT TO, LOWER PAREL, MUMBAI. MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721673000,"product":"SODIUM OXYBATE (GAMMA HYDROXY BUTYRATE SODIUM) (GHB) [ACTIVE PHARMACEUTICAL INGREDIENTS]","address":"CENTAUR HOUSE, SHANTI NAGAR,","city":"MUMBAI ,MAHARASHTRA","supplier":"CENTAUR PHARMACEUTICALS","supplierCountry":"INDIA","foreign_port":"BARCELONA","customer":"TO THE ORDER OF","customerCountry":"SPAIN","quantity":"300.28","actualQuantity":"300.275","unit":"KGS","unitRateFc":"180","totalValueFC":"55206.5","currency":"EUR","unitRateINR":15368.489684455917,"date":"23-Jul-2024","totalValueINR":"4614773.24","totalValueInUsd":"55206.5","indian_port":"Bombay Air","hs_no":"29159099","bill_no":"2634359","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CENTAUR HOUSE, SHANTI NAGAR,, MUMBAI ,MAHARASHTRA","customerAddress":""}]
29-Jan-2021
23-Jul-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Lumryz is an extended-release oral suspension formulation of sodium oxybate being investigated for the treatment of cataplexy or EDS in patients 7 years of age and older with narcolepsy.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Lumryz

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable October 17, 2024

blank

01

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : Lumryz is an extended-release oral suspension formulation of sodium oxybate being investigated for the treatment of cataplexy or EDS in patients 7 years of age and older with narcolepsy.

Brand Name : Lumryz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

October 17, 2024

blank

Details:

Lumryz is an investigational, extended-release oral suspension formulation of sodium oxybate being investigated for the treatment of idiopathic hypersomnia.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Lumryz

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 31, 2024

blank

02

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : Lumryz is an investigational, extended-release oral suspension formulation of sodium oxybate being investigated for the treatment of idiopathic hypersomnia.

Brand Name : Lumryz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

July 31, 2024

blank

Details:

sodium oxybate oral solution indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients seven years of age and older with narcolepsy.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Xyrem-Generic

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 03, 2023

blank

03

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : sodium oxybate oral solution indicated for the treatment of cataplexy or excessive daytime sleepiness (EDS) in patients seven years of age and older with narcolepsy.

Brand Name : Xyrem-Generic

Molecule Type : Small molecule

Upfront Cash : Not Applicable

July 03, 2023

blank

Details:

Lumryz (sodium oxybate) is a once-nightly formulation of the USFDA approved central nervous system depressant sodium oxybate in development for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Lumryz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 05, 2023

blank

04

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : Lumryz (sodium oxybate) is a once-nightly formulation of the USFDA approved central nervous system depressant sodium oxybate in development for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.

Brand Name : Lumryz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

June 05, 2023

blank

Details:

Lumryz (sodium oxybate) is a once-nightly formulation of the USFDA approved central nervous system depressant sodium oxybate in development for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Lumryz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 01, 2023

blank

05

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : Lumryz (sodium oxybate) is a once-nightly formulation of the USFDA approved central nervous system depressant sodium oxybate in development for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.

Brand Name : Lumryz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

May 01, 2023

blank

Details:

The offering will be used for obtaining FDA approval of company's lead candidate, Lumryz, an investigational, extended-release formulation of sodium oxybate for the treatment of cataplexy or EDS in adults with narcolepsy.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Lumryz

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Jefferies LLC

Deal Size: $125.0 million Upfront Cash: Undisclosed

Deal Type: Public Offering March 29, 2023

blank

06

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : The offering will be used for obtaining FDA approval of company's lead candidate, Lumryz, an investigational, extended-release formulation of sodium oxybate for the treatment of cataplexy or EDS in adults with narcolepsy.

Brand Name : Lumryz

Molecule Type : Small molecule

Upfront Cash : Undisclosed

March 29, 2023

blank

Details:

The financing will support the potential commercialization of Lumryz (sodium oxybate) for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Lumryz

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: RTW Investments

Deal Size: $75.0 million Upfront Cash: Undisclosed

Deal Type: Agreement March 29, 2023

blank

07

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : The financing will support the potential commercialization of Lumryz (sodium oxybate) for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy.

Brand Name : Lumryz

Molecule Type : Small molecule

Upfront Cash : Undisclosed

March 29, 2023

blank

Details:

Lumryz (sodium oxybate) is a once-nightly formulation of the approved central nervous system depressant sodium oxybate in development for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Lumryz

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 22, 2023

blank

08

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : Lumryz (sodium oxybate) is a once-nightly formulation of the approved central nervous system depressant sodium oxybate in development for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.

Brand Name : Lumryz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

March 22, 2023

blank

Details:

Lumryz (sodium oxybate) is a sodium salt of GHB, a naturally occurring CNS depressant that increases dopamine levels and increases serotonin turnover. It is being developed for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Lumryz

Study Phase: ApprovedProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable March 02, 2023

blank

09

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : Lumryz (sodium oxybate) is a sodium salt of GHB, a naturally occurring CNS depressant that increases dopamine levels and increases serotonin turnover. It is being developed for the treatment of cataplexy or excessive daytime sleepiness in adults with nar...

Brand Name : Lumryz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

March 02, 2023

blank

Details:

Lumryz (sodium oxybate) is a once-nightly formulation of the approved central nervous system depressant sodium oxybate in development for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.


Lead Product(s): Sodium Oxybate

Therapeutic Area: Sleep Brand Name: Lumryz

Study Phase: Phase IIIProduct Type: Small molecule

Sponsor: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable January 24, 2023

blank

10

World Vaccine Congress
Not Confirmed
World Vaccine Congress
Not Confirmed

Details : Lumryz (sodium oxybate) is a once-nightly formulation of the approved central nervous system depressant sodium oxybate in development for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy.

Brand Name : Lumryz

Molecule Type : Small molecule

Upfront Cash : Not Applicable

January 24, 2023

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/10/17/2964979/0/en/Avadel-Pharmaceuticals-Announces-FDA-Approval-of-LUMRYZ-sodium-oxybate-Extended-Release-Oral-Suspension-CIII-for-the-Treatment-of-Cataplexy-or-Excessive-Daytime-Sleepiness-in-Patie.html

GLOBENEWSWIRE
17 Oct 2024

https://www.globenewswire.com/news-release/2024/09/25/2952920/0/en/Avadel-Pharmaceuticals-Announces-Publication-of-Data-Highlighting-Efficacy-of-LUMRYZ-sodium-oxybate-Extended-Release-Oral-Suspension-in-Improving-Narcolepsy-Symptoms-Regardless-of-.html

GLOBENEWSWIRE
25 Sep 2024

https://www.globenewswire.com/news-release/2024/09/03/2939609/0/en/Avadel-Pharmaceuticals-Announces-Publication-of-RESTORE-Data-Highlighting-Challenges-with-Twice-Nightly-Oxybates-and-Strong-Patient-Preference-for-Once-Nightly-LUMRYZ-Dosing-sodium.html

GLOBENEWSWIRE
03 Sep 2024

https://www.globenewswire.com/news-release/2024/08/20/2932758/0/en/Avadel-Pharmaceuticals-Announces-Publication-in-Clinical-Therapeutics-of-Data-Highlighting-Weight-Loss-in-People-with-Narcolepsy-Treated-with-LUMRYZ-sodium-oxybate-Extended-Release.html

GLOBENEWSWIRE
20 Aug 2024

https://www.globenewswire.com/news-release/2024/07/31/2922239/0/en/Avadel-Pharmaceuticals-Announces-First-Patient-Dosed-in-Phase-3-REVITALYZ-Trial-of-LUMRYZ-sodium-oxybate-Extended-Release-Oral-Suspension-for-the-Treatment-of-Idiopathic-Hypersomni.html

GLOBENEWSWIRE
31 Jul 2024
Avadel Shares LUMRYZ Data At SLEEP 2024
Avadel Shares LUMRYZ Data At SLEEP 2024

22 May 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/05/22/2886402/0/en/Avadel-Pharmaceuticals-Shares-New-LUMRYZ-sodium-oxybate-For-Extended-release-Oral-Suspension-CIII-Data-at-SLEEP-2024.html

GLOBENEWSWIRE
22 May 2024

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty